Clik here to view.
Bill Ackman's favorite company is turning on him
Valeant, Bill Ackman's biggest holding, seems to be straying from his vision of its business model.On Monday morning, the embattled pharmaceutical company reported a stellar third-quarter earnings beat...
View ArticleClik here to view.
Bill Ackman is down more than $1 billion on his big Valeant bet
Hedge fund manager Bill Ackman has potentially lost more than $1 billion on paper on his hedge fund's largest stock holding.The Canadian drug company Valeant Pharmaceuticals is getting hammered after...
View ArticleClik here to view.
SHORT SELLER: Here's why pharmaceutical company Valeant looks like Enron
Valeant Pharmaceuticals is being accused of an Enron-like fraud. Short-selling firm Citron Research released a report highlighting Valeant's mysterious relationship with Philidor, a pharmacy that...
View ArticleClik here to view.
It's a hedge fund horror show as Valeant gets crushed
Hedge fund darling Valeant Pharmaceuticals is getting hammered after short-selling-firm Citron Research published a report comparing it to Enron.The Canadian drug company's stock was last down about...
View ArticleClik here to view.
Bill Ackman buys 2 million shares of Valeant after it craters on accusations...
Hedge fund titan Bill Ackman purchased 2 million more shares of Valeant Pharmaceuticals Wednesday amid the stock's decline, CNBC's Scott Wapner reports.The stock was last down 15.7% at about $123.69...
View ArticleClik here to view.
The fraud allegations against Valeant exposed an industry secret that's going...
Whether you believe accounting fraud allegations levied against pharmaceutical-firm Valeant or not, one thing is certain.The pain isn't over — not for Valeant, not for any company in the pharmaceutical...
View ArticleClik here to view.
A company involved with Valeant has shed light on a critical accusation in...
Around 7:10 p.m. ET on Wednesday, Philidor — a specialty-pharmacy company that distributes and bills clients for embattled drug company Valeant Pharmaceuticals — made a statement that helped address...
View ArticleClik here to view.
It is going from bad to worse for Bill Ackman (PAH)
It is not Bill Ackman's week.Another one of the hedge fund titan's big stock holdings is taking a hit. Platform Specialty Products fell 9.8% to about $10.40 per share after the company said that its...
View ArticleClik here to view.
Valeant just tried to explain itself
After a brutal week that lopped $20 billion off Valeant Pharmaceuticals' market cap, the firm explained itself during a conference call to investors on Monday.Immediately it disavowed legal...
View ArticleClik here to view.
Bill Ackman is hosting a call on Friday to talk about his huge money-losing...
Billionaire activist investor Bill Ackman, founder of Pershing Square Capital, is hosting a conference call for investors on Friday morning to discuss his fund's investment in Valeant...
View ArticleClik here to view.
Bill Ackman's fund is down 15.9% this year after Valeant collapsed (VRX, PAH)
Pershing Square Holdings, the publicly traded fund run by hedge fund billionaire Bill Ackman, is having a brutal year.The fund is down 15.9% through October 27, according to a performance update. The...
View ArticleClik here to view.
Wall Street is going to listen in to Bill Ackman defend his Valeant investment
Billionaire activist investor Bill Ackman, founder of Pershing Square Capital, is hosting a conference call for investors Friday morning to discuss his fund's investment in Valeant Pharmaceuticals.The...
View ArticleHerbalife just fired a massive shot at Bill Ackman in an epic one-sentence...
Bill Ackman scheduled a conference call on Friday defending his position in Valeant Pharmaceuticals. Ahead of this call, Herbalife — the nutritional-supplement company Ackman is enthusiastically...
View ArticleClik here to view.
ACKMAN: 'Life will go on for Valeant' (VRX)
Billionaire activist investor Bill Ackman, founder of Pershing Square Capital, is hosting a conference call for investors to discuss his fund's large investment in Valeant Pharmaceuticals."This is a...
View ArticleClik here to view.
Bill Ackman wants us to remember how a young Warren Buffett took advantage of...
Bill Ackman wants people to remember salad oil. In a conference call on Friday defending his stake in Canadian pharmaceutical company Valeant, Ackman recalled an opportunity found by a then-35-year-old...
View ArticleClik here to view.
Here's Bill Ackman's full presentation defending his big Valeant bet (VRX)
Bill Ackman, the billionaire founder of Pershing Square Capital, spent nearly four hours hosting a call defending his massive investment in Valeant Pharmaceuticals.Ackman has lost more than $1 billion...
View ArticleClik here to view.
VALEANT SHORT SELLER: My new report won't have 'anything earth-shattering'
Citron Research founder Andrew Left, the short-seller targeting Valeant Pharmaceuticals, told the Wall Street Journal that his new report scheduled to come out Monday doesn't have "anything...
View ArticleClik here to view.
The short seller targeting Valeant used a full page of his new report to rip...
Short seller Andrew Left slammed hedge fund manager Bill Ackman in his latest report on the embattled drug company Valeant Pharmaceuticals.Ackman and Left are on opposite sides of a debate over...
View ArticleClik here to view.
Bill Ackman's fund is down 19% this year after Valeant cratered
Pershing Square Holdings, the publicly traded vehicle led by hedge fund titan Bill Ackman, is down 19% year to date, according to a performance update.The fund fell 7.3% in October.Ackman had gone into...
View ArticleClik here to view.
Bill Ackman sent Valeant's CEO an intense email the day after the company's...
The Wall Street Journal's Monica Langley has a terrific behind-the-scenes account of Bill Ackman's exchanges with executives at the embattled pharma giant Valeant Pharmaceuticals.Ackman, founder of...
View Article